BioWorld MedTech

Oct. 23, 2014

View Archived Issues

Inside the Beltway:FDA custom device final guidance allows five devices per indication

Beta-O2 treats first patient in Bio-Artificial pancreas trial

Daily M&A: OxySure Systems and Estill to merge, financial details not disclosed

Financings: Nanosphere's 40M share offering could raise more than $21 million

World in Review: Foundation Medicine, WuXi, to offer profiling to biopharma in China

Grants:Antigen Discovery gains SBIR from NIH to develop HIV Microarray chip

Agreeements/contracts

Briefly Noted

Products

MDD's Orthopedics Extra

United European Gastroenterology Meeting: Robotic colonoscopy said to eliminate pain, reduces costs

VIENNA — Discomfort is the leading reason people give for not undergoing a colonoscopy, and the leading cause of non-compliance with this gold standard for colorectal cancer screening. Read More

Reimbursement Review:Rising middle class offset by price pressure in India med-tech market

Today's news in brief

BioWorld

BioWorld briefs for July 8, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

GDE4 blockade promotes remyelination, study finds

BioWorld Science

Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...